Casirivimab-imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients

doi:10.1097/TP.0000000000004087

. 2022 May 1;106(5):e275-e276.

doi: 10.1097/TP.0000000000004087. Epub 2022 Mar 8.

Casirivimab-imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients

Chloé Dimeglio^{1

2

3}, Arnaud Del Bello^{2

4}, Sabine Chapuy-Regaud^{1

2

3}, Laure Esposito⁴, Chloé Danet⁵, Chloé Couat⁴, Jacques Izopet^{1

2

3}, Nassim Kamar^{2

3

4}

Affiliations

¹ Laboratory of Virology, Toulouse Purpan University Hospital, Toulouse, France.
² INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Disease (Infinity), Toulouse, France.
³ Paul Sabatier University, Toulouse, France.
⁴ Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Toulouse, France.
⁵ Department of Pharmacy, Toulouse University Hospital, Toulouse, France.

PMID: 35283456
PMCID: PMC9038236
DOI: 10.1097/TP.0000000000004087

Casirivimab-imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients

Chloé Dimeglio et al. Transplantation. 2022.

. 2022 May 1;106(5):e275-e276.

doi: 10.1097/TP.0000000000004087. Epub 2022 Mar 8.

Authors

Chloé Dimeglio^{1

2

3}, Arnaud Del Bello^{2

4}, Sabine Chapuy-Regaud^{1

2

3}, Laure Esposito⁴, Chloé Danet⁵, Chloé Couat⁴, Jacques Izopet^{1

2

3}, Nassim Kamar^{2

3

4}

Affiliations

¹ Laboratory of Virology, Toulouse Purpan University Hospital, Toulouse, France.
² INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Disease (Infinity), Toulouse, France.
³ Paul Sabatier University, Toulouse, France.
⁴ Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, Toulouse, France.
⁵ Department of Pharmacy, Toulouse University Hospital, Toulouse, France.

PMID: 35283456
PMCID: PMC9038236
DOI: 10.1097/TP.0000000000004087

Abstract

formula image

PubMed Disclaimer

Conflict of interest statement

The authors declare no funding or conflicts of interest.

Cited by

Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.
Papadimitriou-Olivgeris M, Cipriano A, Guggisberg N, Kroemer M, Tschopp J, Manuel O, Golshayan D. Papadimitriou-Olivgeris M, et al. Transpl Int. 2022 Oct 4;35:10721. doi: 10.3389/ti.2022.10721. eCollection 2022. Transpl Int. 2022. PMID: 36267693 Free PMC article.
Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?
Del Bello A, Marion O, Izopet J, Kamar N. Del Bello A, et al. Viruses. 2022 Aug 24;14(9):1860. doi: 10.3390/v14091860. Viruses. 2022. PMID: 36146666 Free PMC article. Review.
Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario.
Krekeler C, Reitnauer L, Bacher U, Khandanpour C, Steger L, Boeckel GR, Klosner J, Tepasse PR, Kemper M, Hennies MT, Mesters R, Stelljes M, Schmitz N, Kerkhoff A, Schliemann C, Mikesch JH, Schmidt N, Lenz G, Bleckmann A, Shumilov E. Krekeler C, et al. Cancers (Basel). 2022 Nov 9;14(22):5512. doi: 10.3390/cancers14225512. Cancers (Basel). 2022. PMID: 36428605 Free PMC article.

References

1. O’Brien MP, Forleo-Neto E, Musser BJ, et al. ; Covid-19 Phase 3 Prevention Trial Team. Subcutaneous REGEN-COV antibody combination to prevent Covid-19. N Engl J Med. 2021;385:1184–1195. - PMC - PubMed
1. Kamar N, Abravanel F, Marion O, et al. . Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661–662. - PMC - PubMed
1. Hall VG, Ferreira VH, Ku T, et al. . Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients. N Engl J Med. 2021;385:1244–1246. - PMC - PubMed
1. National French Health Authority. RONAPREVE (casirivimab-imdevimab) (prophylaxie pré-exposition de l’infection à SARS-CoV-2). Available at https://www.has-sante.fr/jcms/p_3281544/fr/ronapreve-casirivimab-imdevim.... Accessed August 6, 2021.
1. Dimeglio C, Herin F, Martin-Blondel G, et al. . Antibody titers and protection against a SARS-CoV-2 infection. J Infect. 2021;84:248–288. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] O’Brien MP, Forleo-Neto E, Musser BJ, et al. ; Covid-19 Phase 3 Prevention Trial Team. Subcutaneous REGEN-COV antibody combination to prevent Covid-19. N Engl J Med. 2021;385:1184–1195. - PMC - PubMed

[2] O’Brien MP, Forleo-Neto E, Musser BJ, et al. ; Covid-19 Phase 3 Prevention Trial Team. Subcutaneous REGEN-COV antibody combination to prevent Covid-19. N Engl J Med. 2021;385:1184–1195. - PMC - PubMed

[3] Kamar N, Abravanel F, Marion O, et al. . Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661–662. - PMC - PubMed

[4] Kamar N, Abravanel F, Marion O, et al. . Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661–662. - PMC - PubMed

[5] Hall VG, Ferreira VH, Ku T, et al. . Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients. N Engl J Med. 2021;385:1244–1246. - PMC - PubMed

[6] Hall VG, Ferreira VH, Ku T, et al. . Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients. N Engl J Med. 2021;385:1244–1246. - PMC - PubMed

[7] National French Health Authority. RONAPREVE (casirivimab-imdevimab) (prophylaxie pré-exposition de l’infection à SARS-CoV-2). Available at https://www.has-sante.fr/jcms/p_3281544/fr/ronapreve-casirivimab-imdevim.... Accessed August 6, 2021.

[8] National French Health Authority. RONAPREVE (casirivimab-imdevimab) (prophylaxie pré-exposition de l’infection à SARS-CoV-2). Available at https://www.has-sante.fr/jcms/p_3281544/fr/ronapreve-casirivimab-imdevim.... Accessed August 6, 2021.

[9] Dimeglio C, Herin F, Martin-Blondel G, et al. . Antibody titers and protection against a SARS-CoV-2 infection. J Infect. 2021;84:248–288. - PMC - PubMed

[10] Dimeglio C, Herin F, Martin-Blondel G, et al. . Antibody titers and protection against a SARS-CoV-2 infection. J Infect. 2021;84:248–288. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Casirivimab-imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients

Affiliations

Casirivimab-imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous